People · Operator

Brent Backhaus

Named in public records as an officer, director or promoter · active 2015–2020 · Other Technology, Other

2
Companies
3
Filings
$15.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Gene Matters, LLCOther TechnologySeries A$11.3M$281.2M2020
USARAD Holdings, Inc.OtherSeed$4.0M$55.8M2015
Operator network

Brent Backhaus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Danny J. Cunagin · 10 companies · 1 sharedDanny J. CunaginTroy D. Kopischke · 10 companies · 1 sharedTroy D. KopischkeMark E. Sylvester · 3 companies · 1 sharedMark E. SylvesterMark Sylvester · 3 companies · 1 sharedMark SylvesterDanny Cunagin · 2 companies · 1 sharedDanny CunaginJill Davies · 2 companies · 1 sharedJill DaviesTroy Kopischke · 2 companies · 1 sharedTroy KopischkeBrent D. Backhaus · 1 companies · 1 sharedBrent D. BackhausJill D. Davies · 1 companies · 1 sharedJill D. DaviesSteve E. Troutner · 1 companies · 1 sharedSteve E. TroutnerSean Casey · 4 companies · 1 sharedSean CaseyAnupendra Sharma · 1 companies · 1 sharedAnupendra SharmaMichael Yuz · 1 companies · 1 sharedMichael YuzGene Matters, LLC · $11.3M raisedGene Matters, LLCUSARAD Holdings, Inc. · $4.0M raisedUSARAD Holdings, Inc.Brent BackhausBB
Brent Backhaus Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Brent Backhaus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Danny J. Cunagin110
Troy D. Kopischke110
Sean Casey14
Mark Sylvester13
Mark E. Sylvester13
Jill Davies12
Troy Kopischke12
Danny Cunagin12
Anupendra Sharma11
Brent D. Backhaus11
Steve E. Troutner11
Jill D. Davies11
Michael Yuz11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.